1
TÍTULO: Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 study group
AUTORES: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Cindy Marabotti; Eric Van Cutsem;
PUBLICAÇÃO: 2007, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 25, NÚMERO: 22
INDEXADO EM: WOS CrossRef
2
TÍTULO: Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 study group
AUTORES: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Lucile Awad; Eric Van Cutsem;
PUBLICAÇÃO: 2007, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 25, NÚMERO: 22
INDEXADO EM: WOS CrossRef
3
TÍTULO: Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
AUTORES: Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie Laure Risse; Jaffer A Ajani;
PUBLICAÇÃO: 2006, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 24, NÚMERO: 31
INDEXADO EM: WOS CrossRef